Soligenix, Inc. ( SNGX) - Stock Earnings
SNGX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
SNGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.9 million USD | — USD |
| 2026Q1 | -2.8 million USD | — USD |
| 2026Q2 | -2.0 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SNGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.1 million USD | 839359 USD |
| 2024 | -8.3 million USD | 119371 USD |
| 2025 | -11.1 million USD | — USD |
| 2026 Est. | — | — |
SNGX
Price: $0.36
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.47 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16498
Ebitda: -951647Market Capitalization: 5.4 million